According to Natera's latest financial reports the company's current earnings (TTM) are -$0.44 B. In 2022 the company made an earning of -$0.55 B a decrease over its 2021 earnings that were of -$0.48 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.44 B | -20.54% |
2022 | -$0.55 B | 16.07% |
2021 | -$0.48 B | 105.14% |
2020 | -$0.23 B | 86.97% |
2019 | -$0.13 B | -3.92% |
2018 | -$0.13 B | -5.63% |
2017 | -$0.14 B | 41.66% |
2016 | -$95.63 M | 36.07% |
2015 | -$70.28 M | 1264.03% |
2014 | -$5.16 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Vertex Pharmaceuticals VRTX | $4.42 B | -1,118.09% | ๐บ๐ธ USA |
Prothena PRTA | -$0.2 B | -56.04% | ๐ฎ๐ช Ireland |
Paratek Pharmaceuticals
PRTK | -$43.71 M | -89.94% | ๐บ๐ธ USA |